115 related articles for article (PubMed ID: 23240309)
1. [Life-threatening heart failure caused by ADHD medication. Five case reports described].
Wikström G; Kvidal P; Hagström E
Lakartidningen; 2012 Nov 7-13; 109(45):2016-8. PubMed ID: 23240309
[No Abstract] [Full Text] [Related]
2. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
Harpin VA
Arch Dis Child Educ Pract Ed; 2008 Apr; 93(2):58-65. PubMed ID: 18356307
[TBL] [Abstract][Full Text] [Related]
3. Newly approved once-daily formulations of medications for the treatment of Attention Deficit (Hyperactivity) Disorder (ADHD) in children and adolescents.
Roman MW
Issues Ment Health Nurs; 2010 Aug; 31(8):548-9. PubMed ID: 20624025
[No Abstract] [Full Text] [Related]
4. Sleep disturbances and ADHD medications.
Rostain AL
Curr Psychiatry Rep; 2007 Oct; 9(5):399-400. PubMed ID: 17915079
[No Abstract] [Full Text] [Related]
5. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
Golubchik P; Sever J; Weizman A
Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
[TBL] [Abstract][Full Text] [Related]
6. Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Davis M; Mikami AY; Singh H; Merkel RL; Burket R
J Clin Psychopharmacol; 2012 Apr; 32(2):225-30. PubMed ID: 22367664
[TBL] [Abstract][Full Text] [Related]
7. [Comment on the European guidelines for use of delayed action drugs for treatment of hyperkinetic disorders].
Banaschewski T; Döpfner M; Rothenberger A; Steinhausen H-
Z Kinder Jugendpsychiatr Psychother; 2008 Mar; 36(2):77-9. PubMed ID: 18622937
[No Abstract] [Full Text] [Related]
8. Methylphenidate: abuse and addiction.
Prescrire Int; 2012 Oct; 21(131):241. PubMed ID: 23189380
[No Abstract] [Full Text] [Related]
9. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands.
Hodgkins P; Sasané R; Meijer WM
Clin Ther; 2011 Feb; 33(2):188-203. PubMed ID: 21497704
[TBL] [Abstract][Full Text] [Related]
10. Managing stimulant medication for attention-deficit/hyperactivity disorder.
Wender EH
Pediatr Rev; 2001 Jun; 22(6):183-90. PubMed ID: 11389305
[No Abstract] [Full Text] [Related]
11. Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder: and open-label study using an osmotic-controlled release oral delivery system.
Yoo HK; Park S; Wang HR; Lee JS; Kim K; Paik KW; Yum MS; Ko TS
Epileptic Disord; 2009 Dec; 11(4):301-8. PubMed ID: 20007067
[TBL] [Abstract][Full Text] [Related]
12. [Prescribing of stimulants for ADHD in Nordland County].
Asheim H; Nilsen KB; Johansen K; Furu K
Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2360-2. PubMed ID: 17895938
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
14. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
Aanonsen NO
Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
[TBL] [Abstract][Full Text] [Related]
15. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
Sasané R; Hodgkins P; Meijer W
Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165
[TBL] [Abstract][Full Text] [Related]
16. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
[No Abstract] [Full Text] [Related]
17. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
Varley CK; Vincent J; Varley P; Calderon R
Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of methylphenidate.
Daniels SR
J Pediatr; 2009 Jul; 155(1):A3. PubMed ID: 19559283
[No Abstract] [Full Text] [Related]
19. Stimulants for ADHD in child patients with Tourette's syndrome: the issue of relative risk.
Gadow KD; Sverd J
J Dev Behav Pediatr; 1990 Oct; 11(5):269-71; discussion 272. PubMed ID: 1979565
[No Abstract] [Full Text] [Related]
20. Focalin XR for ADHD.
Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
